Cloning expression, monoclonal antibody preparation and serologic study of mammaglobin in breast cancer

Neoplasma

Volumn 58, Issue 5, 2011, Pages 436-440

  Huang, Y ^a   Zhang, H Q ^b   Wang, Q ^c   Song, X G ^b   Wang, G H ^b   Guan, Q ^a   Zhou, W ^a   Huo, F ^a   Yu, C Z ^a   Zeng, Y J ^d  

^a Beijing 307 Hospital   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Breast cancer; Cloning expression; Mammaglobin; Monoclonal antibody; Serologic study

Indexed keywords

MAMMAGLOBIN; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; DIAGNOSTIC AGENT; MAMMAGLOBIN A; TUMOR MARKER; TUMOR PROTEIN; UTEROGLOBIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FEMALE; GENE AMPLIFICATION; HUMAN; HYBRIDOMA CELL CULTURE; IMMUNIZATION; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEROLOGY; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; MIDDLE AGED; PROGNOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 80052901704     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_05_436     Document Type: Article

References (13)

1. WATSON MA, FLEMNG TP. Mammaglobin,a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996;56(4):860-65.
2. GRUNEWALD K, HAUN M, URBANEK M, FIEGL M, Muller-Holzner E, et al. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Inves. 2000;80(7):1071-077. doi:10.1038/ labinvest.3780112.
3. ZACH O, KASPARU H, WAGNER H, KRIEGER O, LUTZ D. Detection of mammaglobin mRNA as a marker for circulating tumor cells in breast carcinoma. Acta Med Austriaca Suppl. 2000;52:13-5.
4. RONCELLA S, FERRO P, BACIGALUPO B, PRONZATO P, TOGNONI A, et al. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood. J Exp Clin Cancer Res. 2005;24(2):265-71.
5. FANGER GR, HOUGHTON RL, RETTER MW, HENDRICKSON RC, BBBCOOK J, et al. Detection of mammaglobin in the sera of patients with breast cancer. Tumor Biol. 2002;23(4):212-21. doi:10.1159/000067251.
6. BERNSTEIN JL, GODBOLD JH, RAPTIS G, WATSON MA, LEVINSON B, et al. Identification of mammaglobin as a novel serum marker for breast cancer. Clin Cancer Res. 2005;11(18):6528-535. doi:10.1158/1078-0432.CCR-05-0415.
7. LI WJ, YING XM, BIOSUN. A software system for computeraided design for molecular biology experiments. Bulletin Of The Academy Of Military Medical Sciences, 2004;28(5):401-04.
8. MIN CJ, TAFRA L, VERBANAC KM. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res. 1998;58(20):4581-584.
9. OUELLETTE RJ, RICHARD D, MAICAS E. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol. 2004;121(5):637-43. doi:10.1309/MMACTXT55L8QTKC1.
10. TAFE LJ, SCHWAB MC, LEFFERTS JA, WELLS WA, TSONGALIS GJ. A validation study of a new molecular diagnostic assay: The Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes. Exp Mol Pathol. 2009 Oct 17. [Epub ahead of print].
11. MANDEL RE, GOYAL A, Douglas-Jones A, WOODS V, GOYAL S, et al. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study. Breast Cancer Res Treat. 2009;115(3):595-600. doi:10.1007/s10549-008-0155-6.
12. IGNATIADIS M, KALLERGI G, NTOULIA M, PERRAKI M, APOSTOLAKI S,et al. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res. 2008;14(9):2593-600. doi:10.1158/1078-0432.CCR-07-4758.
13. ZEHENTNER BK, PERSING DH, DEME A, TOURE P, HAWES SE, et al. Mammaglobin as a Novel Breast Cancer Biomarker: Multigene Reverse Transcription-PCR Assay and Sandwich ELISA. Clin Chem. 2004;50(11):2069-076. doi:10.1373/clinchem.2004.038687.